In his first term, President Trump pledged to boost HIV spending, with the lofty goal of bringing the epidemic to heel by 2030. Now, however, Republicans are seeking deep cuts to HIV funding.

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...

Given that much of our coverage concerns gloomy topics like conflict, humanitarian crises and political discord, it always feels like a breath of fresh air when we’re able to spotlight a good-news ...

Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, thanks to new partnerships with generic manufacturers.

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and highly effective HIV prevention drug for roughly $40 per year beginning in ...

A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of generic production ...

Two Indian drugmakers, Hetero Pharma & Dr Reddy’s Laboratories, set to produce generic lenacapavir. The generic version will be available in low- and middle-income countries at significantly lower ...

Kampala, Uganda | THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between ...

In a bold step towards tackling the HIV epidemic, the Ministry of Health and Wellness is now considering a pilot programme for the first US Food and Drug Administration-approved injectable HIV ...

A new survey launched by Global Black Gay Men Connect is seeking responses from Black gay men and Black trans community members to learn more about the ...

A twice-yearly Human Immunodeficiency Virus prevention injection, hailed as the most promising tool against the virus in decades, has generated mixed ...